{'Year': '2018', 'Month': 'Nov'}
Pharmacogenetic impact of docetaxel on neoadjuvant treatment of breast cancer patients.
This study aimed to investigate the effect of CYP3A4 and CYP3A5 genotypes on clinical outcomes of docetaxel treatment.